Bionano Genomics Inc stock is traded at $1.04, with a volume of 829,401. It is down -5.91% in the last 24 hours and down -23.05% over the past month. Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Previous Close:
$1.10
Open:
$1.12
24h Volume:
829,401
Relative Volume:
3.53
Market Cap:
$14.48M
Revenue:
$28.74M
Net Income/Loss:
-$31.60M
P/E Ratio:
-
EPS:
-$5.08
Net Cash Flow:
-$19.30M
1W Performance:
-5.91%
1M Performance:
-23.05%
6M Performance:
-17.86%
1Y Performance:
-35.31%
1-Day Range:
$0.97$1.12
1-Week Range:
$0.97$1.35
52-Week Range:
$0.97$2.23
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics IncSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
(858) 888-7600Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS